- Stocks
- Pharma & Healthcare
- Family Care Hos
Family Care Hos share price
NSE: FAMILYCAREPharma & HealthcareMedical Care Facilities
Family Care Hos at a glance
With a market capitalisation of ₹16 Cr, it ranks 3701st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was −328.0% in FY25. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹0 Cr (+150.0% year on year) and net profit −₹0 Cr, on a standalone basis. Promoters held 17.47% of the company as of 30 Jun 2026; 65.47% of promoter shares were pledged.
Key numbers
- Market cap
- ₹16 CrRank 3701 on NSE
- Price to book
- 1.44×FY25
- EPS (TTM)
- −₹1.56to Q1 FY27
- ROE
- −328.0%FY25
- ROCE
- 219.1%FY25
- Debt to equity
- 0.25FY25
- Net profit margin
- −558.5%FY25
- Book value / share
- ₹2.49FY25
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Family Care Hos quarterly results
| Quarter | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Revenue YoY | −68.8% | −99.7% | −99.5% | −99.5% | −98.2% | +100.0% | +200.0% | +150.0% |
| Net profit | −₹43 Cr | −₹2 Cr | ₹1 Cr | −₹1 Cr | −₹5 Cr | −₹1 Cr | −₹2 Cr | −₹0 Cr |
| Net profit YoY | −3,534.1% | −287.5% | −88.5% | −404.3% | — | — | −344.4% | — |
| Net margin | −1,115.2% | −7,000.0% | 4,950.0% | −3,500.0% | −6,585.7% | −1,600.0% | −4,033.3% | −840.0% |
| EPS | −₹8.01 | −₹0.39 | ₹0.18 | −₹0.13 | −₹0.85 | −₹0.18 | −₹0.45 | −₹0.08 |
Family Care Hos financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹13 Cr | ₹35 Cr | ₹42 Cr | ₹47 Cr | ₹40 Cr | ₹8 Cr |
| Operating profit | ₹0 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹30 Cr |
| Net profit | ₹0 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹13 Cr | −₹44 Cr |
| EPS (₹) | ₹0.01 | ₹1.27 | ₹1.62 | ₹0.16 | ₹2.32 | −₹8.17 |
| Cash from operations | −₹1 Cr | ₹4 Cr | ₹2 Cr | −₹5 Cr | −₹0 Cr | −₹17 Cr |
| Total debt | ₹7 Cr | ₹4 Cr | ₹2 Cr | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| Shareholders' equity | ₹5 Cr | ₹9 Cr | ₹14 Cr | ₹46 Cr | ₹58 Cr | ₹13 Cr |
Family Care Hos shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 18.54% | 18.54% | 18.54% | 18.54% | 18.54% | 17.47% |
| Domestic institutions | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% | 0.09% |
| Non-institutions | 81.37% | 81.37% | 81.37% | 81.37% | 81.37% | 82.44% |
| Promoter shares pledged | 61.71% | 61.71% | 61.71% | 61.71% | 61.71% | 65.47% |
Family Care Hos vs peers
The listed Pharma & Healthcare companies nearest to Family Care Hos by market capitalisation.
Ask anything about Family Care Hos
Pivot answers on the live chart with evidence you can check, and tests strategies against FAMILYCARE's own history. Try: “Why has FAMILYCARE moved over the last three months?” · “Backtest a 50-day moving-average crossover on FAMILYCARE over five years” · “Compare FAMILYCARE with VANTABIO on margins and valuation”
Frequently asked questions about Family Care Hos
What is the market cap of Family Care Hos?
Family Care Hos' market capitalisation is ₹16 Cr (₹16 Cr) at the 22 Oct 2026 close, ranking 3701st among the NSE companies Pivot tracks.
What is the ROE and ROCE of Family Care Hos?
Return on equity was −328.0% in FY25 and return on capital employed was 219.1% in FY25 (standalone figures).
Is Family Care Hos a debt-free company?
No. Family Care Hos' debt-to-equity ratio was 0.25 in FY25, with total debt of ₹0 Cr.
What were Family Care Hos' latest quarterly results?
For Q1 FY27 (quarter ended 30 Jun 2026), Family Care Hos reported revenue of ₹0 Cr, +150.0% year on year, and net profit of −₹0 Cr.
What is the shareholding pattern of Family Care Hos?
As of 30 Jun 2026: promoters 17.47%, domestic institutions 0.09%, non-institutions 82.44%. 65.47% of promoter shares were pledged.
Who are Family Care Hos' competitors?
The listed Pharma & Healthcare companies closest to Family Care Hos by market cap are Vanta Bioscienc, Venmax Drugs, Zenith Health, Colinz Labs, Starsource Mult and Norris Medicine.
Is Family Care Hos a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Family Care Hos' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on FAMILYCARE against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, standalone where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with F · all NSE stocks · this page as text